"For some people living with HIV, taking a pill every single day is a major challenge," said Kristina Brooks, PharmD, University of Colorado Anschutz Skaggs School of Pharmacy assistant professor and study co-author. "This trial shows that a monthly injectable option can significantly reduce the risk of treatment failure for those who need a different approach."
CU Anschutz
Pharmacy and Pharmaceutical Sciences Building
12850 East Montview Boulevard
Aurora, CO 80045